HCP2303

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Healthy

Phase 1

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

CompletedNCT06346184

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2024-05-02End: 2024-06-10Updated: 2024-07-16

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

CompletedNCT06357910

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2024-05-17End: 2024-07-01Updated: 2024-07-16